| Breakdown | TTM | Dec 2024 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.86B | 2.60B | 2.72B | 2.32B | 2.01B | 1.90B |
| Gross Profit | 444.30M | 376.90M | 408.80M | 295.70M | 276.80M | 265.70M |
| EBITDA | 308.60M | 253.60M | 280.70M | 220.00M | 199.00M | 185.50M |
| Net Income | 148.00M | 113.10M | 134.30M | 111.40M | 103.50M | 92.50M |
Balance Sheet | ||||||
| Total Assets | 1.72B | 1.38B | 1.53B | 1.26B | 1.14B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 10.30M | 27.00M | 5.90M | 20.40M | 200.00K | 39.90M |
| Total Debt | 145.00M | 126.50M | 178.30M | 121.70M | 106.20M | 131.40M |
| Total Liabilities | 693.00M | 472.50M | 543.30M | 421.50M | 373.60M | 355.00M |
| Stockholders Equity | 1.02B | 911.50M | 987.90M | 842.90M | 768.90M | 686.10M |
Cash Flow | ||||||
| Free Cash Flow | 27.70M | 127.90M | 78.70M | 64.10M | 64.70M | 109.00M |
| Operating Cash Flow | 206.70M | 228.40M | 216.30M | 149.20M | 158.40M | 180.90M |
| Investing Cash Flow | -228.90M | -123.30M | -160.40M | -83.80M | -130.90M | -81.80M |
| Financing Cash Flow | 23.80M | -93.40M | -77.00M | -45.30M | -66.30M | -81.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.62B | 17.73 | 15.07% | 2.07% | 6.96% | 28.47% | |
76 Outperform | £1.49B | 11.34 | 9.47% | 1.60% | 0.50% | 20.52% | |
71 Outperform | £444.75M | 11.36 | 12.72% | 7.04% | 8.58% | -15.81% | |
70 Outperform | £1.04B | 18.13 | 12.23% | 0.83% | 7.74% | 30.09% | |
65 Neutral | £1.61B | 47.49 | 2.48% | 5.45% | 26.84% | -81.73% | |
64 Neutral | £1.33B | 35.63 | 5.88% | 2.56% | 0.59% | -41.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
Cranswick plc has announced that as of November 28, 2025, the total number of ordinary shares in issue is 54,280,991, with each share carrying one vote. This figure is relevant for shareholders to determine their interest in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Cranswick plc reported strong interim results for the 26 weeks ending 27 September 2025, with a 10.4% increase in revenue to £1,468.3m and a 13.5% rise in adjusted group operating profit to £113.0m. The company achieved significant growth in its poultry and gourmet products segments, supported by new business wins and strategic acquisitions. Despite an increase in net debt due to capital expenditures and acquisitions, Cranswick completed a £360m refinancing to support future growth. The company’s strategic investments in automation and capacity expansion are expected to enhance operational efficiencies and sustain its market position.
Cranswick PLC announced that Director Christopher Aldersley has acquired ordinary shares as part of the Cranswick 2024 Buy As You Earn Share Incentive Plan. This transaction, conducted on the London Stock Exchange, reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially enhancing stakeholder confidence in its governance and strategic direction.
Cranswick plc has announced that as of October 31, 2025, the total number of ordinary shares in issue is 54,280,880, with each share carrying one vote. This figure is significant for shareholders as it serves as the denominator for calculating changes in their shareholding interests under the Financial Conduct Authority’s Disclosure and Transparency Rules.
Cranswick plc announced that Director Christopher Aldersley acquired ordinary shares under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition, which included both ‘Partnership Shares’ and ‘Matching Shares,’ reflects the company’s ongoing commitment to aligning management interests with shareholder value, potentially strengthening investor confidence and enhancing stakeholder engagement.
Cranswick plc has announced that as of October 1, 2025, the total number of ordinary shares in the company is 54,279,344, each carrying one vote. This figure is crucial for shareholders to determine their interest in the company’s share capital according to the Financial Conduct Authority’s Disclosure and Transparency Rules.
Cranswick plc announced that Director Christopher Aldersley has acquired ordinary shares as ‘Partnership Shares’ under the company’s 2024 Buy As You Earn Share Incentive Plan. This acquisition, part of a regular monthly purchase program, reflects ongoing engagement with the company’s stock incentive schemes, potentially indicating confidence in Cranswick’s market position and future prospects.
Cranswick plc announced a transaction involving the reinvestment of dividends into shares by Sophia Bottomley, who is closely associated with John Mark Bottomley, a director at Cranswick. The transaction, involving 42 ordinary shares at a price of 5205.6p each, took place on the London Stock Exchange on September 12, 2025. This move reflects the company’s ongoing commitment to shareholder value and may indicate confidence in Cranswick’s market position and future prospects.
Cranswick plc announced a transaction involving Saskia Bottomley, who is closely associated with John Mark Bottomley, a Director at the company. The transaction involved the reinvestment of dividends into ordinary shares, with a total of 57 shares purchased at a price of 5205.6 pence each on the London Stock Exchange. This transaction reflects a strategic reinvestment approach by individuals closely linked to the company’s leadership, potentially indicating confidence in Cranswick’s market position and future prospects.
Cranswick plc has announced that as of 10 September 2025, the company has a total of 54,270,567 ordinary shares in issue, each carrying one vote. This information is crucial for shareholders to determine their notification requirements regarding their interest in the company’s share capital under the Financial Conduct Authority’s Disclosure and Transparency Rules.